Irhythm Technologies (IRTC) Stock Forecast & Price Target

Compare

578 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

IRTC Analyst Ratings

Strong Buy

9 Buy

0 Hold

0 Sell

Based on 9 analysts giving stock ratings to

Irhythm

Technologies

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

IRTC Stock 12 Month Forecast

Average Price Target

$150.63

▲(9.95%Upside)

Based on 9 Wall Street analysts offering 12 month price targets for Irhythm Technologies in the last 3 months. The average price target is $150.63 with a high forecast of $167.00 and a low forecast of $130.00. The average price target represents a 9.95% change from the last price of $137.00.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"69":"$69","168":"$168","93.75":"$93.8","118.5":"$118.5","143.25":"$143.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":167,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$167.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":150.63,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$150.63</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":130,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$130.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[69,93.75,118.5,143.25,168],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,145.95,147.56923076923076,149.18846153846152,150.8076923076923,152.42692307692306,154.04615384615383,155.6653846153846,157.2846153846154,158.90384615384616,160.52307692307693,162.1423076923077,163.76153846153846,165.38076923076923,{"y":167,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,145.95,146.31,146.67,147.03,147.39,147.75,148.10999999999999,148.47,148.82999999999998,149.19,149.54999999999998,149.91,150.26999999999998,{"y":150.63,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,145.95,144.72307692307692,143.49615384615385,142.26923076923077,141.04230769230767,139.8153846153846,138.58846153846153,137.36153846153846,136.1346153846154,134.90769230769232,133.68076923076922,132.45384615384614,131.22692307692307,{"y":130,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":88.21,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":106.45,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.22,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.88,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.58,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.04,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.9,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90.17,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.85,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":106.88,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.59,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":140.65,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145.95,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$167.00

Average Price Target$150.63

Lowest Price Target$130.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$131

Hold

-4.38%

Downside

Reiterated

07/16/25

The overall score reflects significant financial and technical challenges for iRhythm Technologies. While the company experiences robust revenue growth and international expansion, high leverage, persistent losses, and negative technical indicators weigh heavily on the stock. The valuation also presents a concern due to a negative P/E ratio, overshadowing the positive earnings call sentiment.

David RescottRobert W. Baird

Robert W. Baird

$150→$160

Buy

16.79%

Upside

Reiterated

07/16/25

Irhythm Technologies (IRTC) Receives a Buy from Robert W. Baird

Marie ThibaultBTIG

BTIG

$165

Buy

20.44%

Upside

Reiterated

07/15/25

BTIG maintains iRhythm estimates after CMS fee schedule proposalBTIG maintains iRhythm estimates after CMS fee schedule proposal

Kallum TitchmarshMorgan Stanley

Morgan Stanley

$160→$147

Buy

7.30%

Upside

Reiterated

07/15/25

iRhythm price target lowered to $147 from $160 at Morgan StanleyiRhythm price target lowered to $147 from $160 at Morgan Stanley

Margaret KaczorWilliam Blair

William Blair

―

Buy

―

Reiterated

06/05/25

Positive Outlook for iRhythm Technologies Driven by Strategic Partnerships and Consistent Growth

Nathan TreybeckWells Fargo

Wells Fargo

$130

Buy

-5.11%

Downside

Assigned

06/02/25

Irhythm Technologies: Strong Market Position and Growth Potential Justify Buy Rating

Joanne WuenschCiti

Citi

$130→$167

Buy

21.90%

Upside

Reiterated

05/23/25

iRhythm price target raised to $167 from $130 at CitiiRhythm price target raised to $167 from $130 at Citi

Richard NewitterTruist Financial

Truist Financial

$120→$146

Buy

6.57%

Upside

Reiterated

05/05/25

Truist Financial Reaffirms Their Buy Rating on Irhythm Technologies (IRTC)

David SaxonNeedham

Needham

$138→$151

Buy

10.22%

Upside

Reiterated

05/02/25

Irhythm Technologies: Strong Q1 2025 Performance and Raised Price Target Reinforce Buy Rating

William PlovanicCanaccord Genuity

Canaccord Genuity

$152→$139

Buy

1.46%

Upside

Reiterated

05/01/25

Irhythm Technologies: Strong Performance and Growth Potential Justify Buy Rating

Suraj KaliaOppenheimer

Oppenheimer

$120→$130

Buy

-5.11%

Downside

Reiterated

02/21/25

iRhythm price target raised to $130 from $120 at OppenheimeriRhythm price target raised to $130 from $120 at Oppenheimer

Allen GongJ.P. Morgan

J.P. Morgan

$97→$145

Buy

5.84%

Upside

Reiterated

02/21/25

iRhythm Technologies (IRTC) PT Raised to $145 at JPMorganJPMorgan analyst Robbie Marcus raised the price target on iRhythm Technologies (NASDAQ: IRTC) to $145.00 (from $97.00) while maintaining a Overweight rating.

David RomanGoldman Sachs

Goldman Sachs

$81→$91

Hold

-33.58%

Downside

Reiterated

12/16/24

iRhythm Technologies (IRTC) PT Raised to $91 at Goldman SachsGoldman Sachs analyst David Roman raised the price target on iRhythm Technologies (NASDAQ: IRTC) to $91.00 (from $81.00) while maintaining a Neutral rating.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$131

Hold

-4.38%

Downside

Reiterated

07/16/25

David RescottRobert W. Baird

Robert W. Baird

$150→$160

Buy

16.79%

Upside

Reiterated

07/16/25

Irhythm Technologies (IRTC) Receives a Buy from Robert W. Baird

Marie ThibaultBTIG

BTIG

$165

Buy

20.44%

Upside

Reiterated

07/15/25

BTIG maintains iRhythm estimates after CMS fee schedule proposalBTIG maintains iRhythm estimates after CMS fee schedule proposal

Kallum TitchmarshMorgan Stanley

Morgan Stanley

$160→$147

Buy

7.30%

Upside

Reiterated

07/15/25

iRhythm price target lowered to $147 from $160 at Morgan StanleyiRhythm price target lowered to $147 from $160 at Morgan Stanley

Margaret KaczorWilliam Blair

William Blair

―

Buy

―

Reiterated

06/05/25

Positive Outlook for iRhythm Technologies Driven by Strategic Partnerships and Consistent Growth

Nathan TreybeckWells Fargo

Wells Fargo

$130

Buy

-5.11%

Downside

Assigned

06/02/25

Irhythm Technologies: Strong Market Position and Growth Potential Justify Buy Rating

Joanne WuenschCiti

Citi

$130→$167

Buy

21.90%

Upside

Reiterated

05/23/25

iRhythm price target raised to $167 from $130 at CitiiRhythm price target raised to $167 from $130 at Citi

Richard NewitterTruist Financial

Truist Financial

$120→$146

Buy

6.57%

Upside

Reiterated

05/05/25

Truist Financial Reaffirms Their Buy Rating on Irhythm Technologies (IRTC)

David SaxonNeedham

Needham

$138→$151

Buy

10.22%

Upside

Reiterated

05/02/25

Irhythm Technologies: Strong Q1 2025 Performance and Raised Price Target Reinforce Buy Rating

William PlovanicCanaccord Genuity

Canaccord Genuity

$152→$139

Buy

1.46%

Upside

Reiterated

05/01/25

Irhythm Technologies: Strong Performance and Growth Potential Justify Buy Rating

Suraj KaliaOppenheimer

Oppenheimer

$120→$130

Buy

-5.11%

Downside

Reiterated

02/21/25

iRhythm price target raised to $130 from $120 at OppenheimeriRhythm price target raised to $130 from $120 at Oppenheimer

Allen GongJ.P. Morgan

J.P. Morgan

$97→$145

Buy

5.84%

Upside

Reiterated

02/21/25

David RomanGoldman Sachs

Goldman Sachs

$81→$91

Hold

-33.58%

Downside

Reiterated

12/16/24

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Irhythm Technologies

1 Month

xxx

Success Rate

13/22 ratings generated profit

Average Return

+2.89%

reiterated a xxx

rating 2 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 59.09% of your transactions generating a profit, with an average return of +2.89% per trade.

3 Months

xxx

Success Rate

12/20 ratings generated profit

Average Return

+2.76%

reiterated a xxx

rating 5 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +2.76% per trade.

1 Year

David RescottRobert W. Baird

Success Rate

10/22 ratings generated profit

Average Return

+9.09%

reiterated a buy rating 2 days ago

Copying David Rescott's trades and holding each position for 1 Year would result in 45.45% of your transactions generating a profit, with an average return of +9.09% per trade.

2 Years

xxx

Success Rate

16/23 ratings generated profit

Average Return

+18.44%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 69.57% of your transactions generating a profit, with an average return of +18.44% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IRTC Analyst Recommendation Trends

Rating

Feb 25

Apr 25

May 25

Jun 25

Jul 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, IRTC has received 16 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. IRTC average Analyst price target in the past 3 months is 150.63.

Each month's total comprises the sum of three months' worth of ratings.

IRTC Financial Forecast

IRTC Earnings Forecast

Next quarter’s earnings estimate for IRTC is -$0.51 with a range of -$0.63 to -$0.32. The previous quarter’s EPS was -$0.97. IRTC beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.18% of the time in the same period. In the last calendar year IRTC has Preformed in-line its overall industry.

IRTC Sales Forecast

Next quarter’s sales forecast for IRTC is $173.98M with a range of $173.00M to $175.48M. The previous quarter’s sales results were $158.68M. IRTC beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.51% of the time in the same period. In the last calendar year IRTC has Preformed in-line its overall industry.

IRTC Stock Forecast FAQ

What is IRTC’s average 12-month price target, according to analysts?

Based on analyst ratings, Irhythm Technologies’s 12-month average price target is 150.63.

What is IRTC’s upside potential, based on the analysts’ average price target?

Irhythm Technologies has 9.95% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is IRTC a Buy, Sell or Hold?

Irhythm Technologies has a consensus rating of Strong Buy which is based on 9 buy ratings, 0 hold ratings and 0 sell ratings.

What is Irhythm Technologies’s price target?

The average price target for Irhythm Technologies is 150.63. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $167.00 ,the lowest forecast is $130.00. The average price target represents 9.95% Increase from the current price of $137.

What do analysts say about Irhythm Technologies?

Irhythm Technologies’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.

How can I buy shares of IRTC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Irhythm Technologies (IRTC) Stock Forecast & Price Target

IRTC Analyst Ratings

IRTC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Irhythm Technologies

IRTC Analyst Recommendation Trends

IRTC Financial Forecast

IRTC Earnings Forecast

IRTC Sales Forecast

IRTC Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts